770 related articles for article (PubMed ID: 17683525)
21. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
Licht AH; Raab S; Hofmann U; Breier G
Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
[TBL] [Abstract][Full Text] [Related]
22. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation.
Heidmann D; Lehner CF
Dev Genes Evol; 2001 Sep; 211(8-9):458-65. PubMed ID: 11685583
[TBL] [Abstract][Full Text] [Related]
23. Expression of Cre recombinase in dopaminoceptive neurons.
Lemberger T; Parlato R; Dassesse D; Westphal M; Casanova E; Turiault M; Tronche F; Schiffmann SN; Schütz G
BMC Neurosci; 2007 Jan; 8():4. PubMed ID: 17201924
[TBL] [Abstract][Full Text] [Related]
24. Cross-contamination with tamoxifen induces transgene expression in non-exposed inducible transgenic mice.
Brake RL; Simmons PJ; Begley CG
Genet Mol Res; 2004 Dec; 3(4):456-62. PubMed ID: 15688312
[TBL] [Abstract][Full Text] [Related]
25. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse.
Schnütgen F; Doerflinger N; Calléja C; Wendling O; Chambon P; Ghyselinck NB
Nat Biotechnol; 2003 May; 21(5):562-5. PubMed ID: 12665802
[TBL] [Abstract][Full Text] [Related]
26. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.
Chiba H; Chambon P; Metzger D
Exp Cell Res; 2000 Nov; 260(2):334-9. PubMed ID: 11035928
[TBL] [Abstract][Full Text] [Related]
27. Efficient inducible Pan-neuronal cre-mediated recombination in SLICK-H transgenic mice.
Heimer-McGinn V; Young P
Genesis; 2011 Dec; 49(12):942-9. PubMed ID: 21671347
[TBL] [Abstract][Full Text] [Related]
28. Sustained somatic gene inactivation by viral transfer of Cre recombinase.
Rohlmann A; Gotthardt M; Willnow TE; Hammer RE; Herz J
Nat Biotechnol; 1996 Nov; 14(11):1562-5. PubMed ID: 9634821
[TBL] [Abstract][Full Text] [Related]
29. Inducible transgenic mouse models.
Saunders TL
Methods Mol Biol; 2011; 693():103-15. PubMed ID: 21080277
[TBL] [Abstract][Full Text] [Related]
30. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
[TBL] [Abstract][Full Text] [Related]
31. Transgenic mice for conditional gene manipulation in astroglial cells.
Slezak M; Göritz C; Niemiec A; Frisén J; Chambon P; Metzger D; Pfrieger FW
Glia; 2007 Nov; 55(15):1565-76. PubMed ID: 17823970
[TBL] [Abstract][Full Text] [Related]
32. Stage-specific conditional mutagenesis in mouse embryonic stem cell-derived neural cells and postmitotic neurons by direct delivery of biologically active Cre recombinase.
Haupt S; Edenhofer F; Peitz M; Leinhaas A; Brüstle O
Stem Cells; 2007 Jan; 25(1):181-8. PubMed ID: 16960133
[TBL] [Abstract][Full Text] [Related]
33. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
[TBL] [Abstract][Full Text] [Related]
34. A Cre gene directed by a human TSPY promoter is specific for germ cells and neurons.
Kido T; Lau YF
Genesis; 2005 Aug; 42(4):263-75. PubMed ID: 16035036
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells.
Leone DP; Genoud S; Atanasoski S; Grausenburger R; Berger P; Metzger D; Macklin WB; Chambon P; Suter U
Mol Cell Neurosci; 2003 Apr; 22(4):430-40. PubMed ID: 12727441
[TBL] [Abstract][Full Text] [Related]
36. Generation of Cre recombinase-expressing transgenic mice using bacterial artificial chromosomes.
Parkitna JR; Engblom D; Schütz G
Methods Mol Biol; 2009; 530():325-42. PubMed ID: 19266340
[TBL] [Abstract][Full Text] [Related]
37. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
[TBL] [Abstract][Full Text] [Related]
38. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium.
el Marjou F; Janssen KP; Chang BH; Li M; Hindie V; Chan L; Louvard D; Chambon P; Metzger D; Robine S
Genesis; 2004 Jul; 39(3):186-93. PubMed ID: 15282745
[TBL] [Abstract][Full Text] [Related]
39. Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate.
Kiermayer C; Conrad M; Schneider M; Schmidt J; Brielmeier M
Genesis; 2007 Jan; 45(1):11-6. PubMed ID: 17216603
[TBL] [Abstract][Full Text] [Related]
40. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium.
Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML
Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
